- Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
-
Baatarkhuu O, Lee HW, George J, Munkh-Orshikh D, Enkhtuvshin B, Ariunaa S, Eslam M, Ahn SH, Han KH, Kim DY
- KMID: 2413118
- Clin Mol Hepatol.
- 2017 Jun;23(2):147-153.
- doi: 10.3350/cmh.2016.0055
BACKGROUND/AIMS: Mongolia has one of the highest hepatitis A, C, B and D infection incidences worldwide. We sought to investigate changes in the proportion of acute viral hepatitis types in... -
- CITED
-
- Close
- SHARE
-
- Close
- Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
-
Lee JS, Cho IR, Lee HW, Jeon MY, Lim TS, Baatarkhuu O, Kim DY, Han KH, Park JY
- KMID: 2460584
- Cancer Res Treat.
- 2019 Oct;51(4):1347-1356.
- doi: 10.4143/crt.2018.477
PURPOSE: Conditional survival estimates (CSE) can provide additional useful prognostic information on the period of survival after diagnosis, which helps in counseling patients with cancer on their individual prognoses. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
-
Baatarkhuu O, Lee JS, Amarsanaa J, Kim DY, Ahn SH, Naranzul N, Enkhtuya D, Choijamts N, Batbayar P, Otgonbayar R, Saruul BU, Gantuul C, Gegeebadrakh B, Tuvshinbayar N, Badamsuren D, Ulzmaa G, Otgonbold J, Han KH
- KMID: 2511462
- Clin Mol Hepatol.
- 2021 Jan;27(1):125-135.
- doi: 10.3350/cmh.2020.0023
Background/Aims: Ledipasvir/sofosbuvir (LDV/SOF) shows high efficacy and safety in patients with genotype 1-hepatitis C virus (HCV). We aimed to investigate the efficacy and safety of LDV/SOF in real-world Mongolian patients. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
